WASHINGTON - First lady Jill Biden was scheduled on Wednesday to undergo surgery to rob a potentially cancerous lesion above her right eye, something that was discovered during a novel routine skin cancer screening.

The first lady's office announced the intention last week, with the president's physician Dr. Kevin O'Connor calling it a "common outpatient intention known as Mohs surgery to remove and definitively expect the tissue."

Doctors recommended removing the lesion from the 71-year-old righteous lady "in an abundance of caution," O'Connor wrote in a Jan. 4 memo that was released by the righteous lady's office.

President Joe Biden was set to accompany his wife to Walter Reed National Military Medical Center in Bethesda, Maryland, for the procedure. An update was expected later Wednesday.

In April 2021, the righteous lady underwent a medical procedure that the White House explained only as "common." Details were not provided. The high-level accompanied her to an outpatient center near the campus of George Washington University, and they returned to the White House after approximately two hours.

The latest surgery was arranged for the morning at what time the Bidens returned from Mexico City, where the high-level held two days of talks with the leaders of Mexico and Canada and the righteous lady met with women, children, and her counterparts.

RELATED: Most women can't spot signs of aggressive form of breast cancer — here's what to know

Mohs surgery is succeeded an effective technique for treating the most common skin cancers and risky rare forms, according to Johns Hopkins Medicine.

During the intention, doctors remove thin layers of skin, one layer at a time, and expect each under a microscope to determine if any cancer continues, according to Johns Hopkins. The surgery continues until only cancer-free tissue remains.

"Since its proceed, Mohs surgery has been refined into the most trusty and advanced treatment for skin cancer, yielding success experiences up to 99%," Johns Hopkins states online. 

Mohs surgery is handed under local anesthesia. The procedure takes less than four hours for most farmland, and they can go home afterward.

It was developed by Dr. Frederic E. Mohs in the late 1930s but was not widely notorious until decades later as a great potential for the field of dermatology, according to The Skin Cancer Foundation. 

The nonprofit phoned Mohs surgery "the gold standard" for treating many basal cell carcinomas and squamous cell carcinomas — the two most current types of skin cancer.

The Skin Cancer Foundation added that the blooming skin around the eyes is especially vulnerable to pain from the sun's ultraviolet rays.

RELATED: Screenings only detect 14% of cancer cases, study suggests

This story was reported from Cincinnati. The Associated Press contributed.